By Bryan Spiegelberg, PhD June 12, 2023
"You know it. We know it – life science investments have lulled over the past year, with much of that lull due to the state of the economy at large.
All job sectors are feeling the hurt, and the life sciences are no exception. While there’s always going to be a need for new medicines and medical devices, investors have become choosier in how they spend their money.
Read the full article on BioBuzz